Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

TAOK3, a Regulator of LCK-SHP-1 Crosstalk during TCR Signaling.

Ormonde JVS, Nie Y, Madrenas J.

Crit Rev Immunol. 2019;39(1):59-81. doi: 10.1615/CritRevImmunol.2019030480.

PMID:
31679194
2.

Correction to: Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959-2016.

Acosta E, Hallman SA, Dillon LY, Ouellette N, Bourbeau R, Herring DA, Inwood K, Earn DJD, Madrenas J, Miller MS, Gagnon A.

Demography. 2019 Oct 28. doi: 10.1007/s13524-019-00824-z. [Epub ahead of print]

PMID:
31659681
3.

Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959-2016.

Acosta E, Hallman SA, Dillon LY, Ouellette N, Bourbeau R, Herring DA, Inwood K, Earn DJD, Madrenas J, Miller MS, Gagnon A.

Demography. 2019 Oct;56(5):1723-1746. doi: 10.1007/s13524-019-00809-y. Erratum in: Demography. 2019 Oct 28;:.

4.

TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1-Mediated Inactivation of LCK.

Ormonde JVS, Li Z, Stegen C, Madrenas J.

J Immunol. 2018 Dec 1;201(11):3431-3442. doi: 10.4049/jimmunol.1800284. Epub 2018 Oct 29.

5.

Experiments on MEMS Integration in 0.25 μm CMOS Process.

Michalik P, Fernández D, Wietstruck M, Kaynak M, Madrenas J.

Sensors (Basel). 2018 Jun 30;18(7). pii: E2111. doi: 10.3390/s18072111.

6.

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.

Gagnon A, Acosta E, Hallman S, Bourbeau R, Dillon LY, Ouellette N, Earn DJD, Herring DA, Inwood K, Madrenas J, Miller MS.

mBio. 2018 Jan 16;9(1). pii: e02091-17. doi: 10.1128/mBio.02091-17.

7.

Staphylococcal Superantigens Use LAMA2 as a Coreceptor To Activate T Cells.

Li Z, Zeppa JJ, Hancock MA, McCormick JK, Doherty TM, Hendy GN, Madrenas J.

J Immunol. 2018 Feb 15;200(4):1471-1479. doi: 10.4049/jimmunol.1701212. Epub 2018 Jan 15.

8.

Action potential propagation: ion current or intramembrane electric field?

Martí A, Pérez JJ, Madrenas J.

Gen Physiol Biophys. 2018 Jan;37(1):71-82. doi: 10.4149/gpb_2017017. Epub 2017 Nov 11.

PMID:
29125128
9.

Notch activation is required for downregulation of HoxA3-dependent endothelial cell phenotype during blood formation.

Sanghez V, Luzzi A, Clarke D, Kee D, Beuder S, Rux D, Osawa M, Madrenas J, Chou TF, Kyba M, Iacovino M.

PLoS One. 2017 Oct 26;12(10):e0186818. doi: 10.1371/journal.pone.0186818. eCollection 2017.

10.

SNAVA-A real-time multi-FPGA multi-model spiking neural network simulation architecture.

Sripad A, Sanchez G, Zapata M, Pirrone V, Dorta T, Cambria S, Marti A, Krishnamourthy K, Madrenas J.

Neural Netw. 2018 Jan;97:28-45. doi: 10.1016/j.neunet.2017.09.011. Epub 2017 Oct 5.

PMID:
29054036
11.

Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.

Peres AG, Zamboni R, King IL, Madrenas J.

J Leukoc Biol. 2017 Dec;102(6):1471-1480. doi: 10.1189/jlb.4A0617-218RR. Epub 2017 Oct 10.

PMID:
29018148
12.

Stomatin-like protein 2 deficiency results in impaired mitochondrial translation.

Mitsopoulos P, Lapohos O, Weraarpachai W, Antonicka H, Chang YH, Madrenas J.

PLoS One. 2017 Jun 27;12(6):e0179967. doi: 10.1371/journal.pone.0179967. eCollection 2017.

13.

HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.

Levast B, Barblu L, Coutu M, Prévost J, Brassard N, Peres A, Stegen C, Madrenas J, Kaufmann DE, Finzi A.

PLoS One. 2017 Mar 27;12(3):e0174550. doi: 10.1371/journal.pone.0174550. eCollection 2017.

14.

Bacterial immune evasion via an IL-10 mediated host response, a novel pathophysiologic mechanism for chronic rhinosinusitis.

Schwartz JS, Al-Mot S, Endam MF, Alromaih S, Madrenas J, Desrosiers M.

Rhinology. 2017 Sep 1;55(3):227-233. doi: 10.4193/Rhin16.199.

PMID:
28315920
15.

Topical probiotics as a therapeutic alternative for chronic rhinosinusitis: A preclinical proof of concept.

Schwartz JS, Peres AG, Mfuna Endam L, Cousineau B, Madrenas J, Desrosiers M.

Am J Rhinol Allergy. 2016 Nov 1;30(6):202-205. doi: 10.2500/ajra.2016.30.4372.

PMID:
28124641
16.

Staphylococcus aureus Downregulates IP-10 Production and Prevents Th1 Cell Recruitment.

Li Z, Levast B, Madrenas J.

J Immunol. 2017 Mar 1;198(5):1865-1874. doi: 10.4049/jimmunol.1601336. Epub 2017 Jan 25.

17.

The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L.

Wai T, Saita S, Nolte H, Müller S, König T, Richter-Dennerlein R, Sprenger HG, Madrenas J, Mühlmeister M, Brandt U, Krüger M, Langer T.

EMBO Rep. 2016 Dec;17(12):1844-1856. Epub 2016 Oct 13.

18.

Integration of GMR Sensors with Different Technologies.

Cubells-Beltrán MD, Reig C, Madrenas J, De Marcellis A, Santos J, Cardoso S, Freitas PP.

Sensors (Basel). 2016 Jun 22;16(6). pii: E939. doi: 10.3390/s16060939.

19.

Immunomodulation and Disease Tolerance to Staphylococcus aureus.

Li Z, Peres AG, Damian AC, Madrenas J.

Pathogens. 2015 Nov 13;4(4):793-815. doi: 10.3390/pathogens4040793. Review.

20.

Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis.

Miller MS, Rialdi A, Ho JS, Tilove M, Martinez-Gil L, Moshkina NP, Peralta Z, Noel J, Melegari C, Maestre AM, Mitsopoulos P, Madrenas J, Heinz S, Benner C, Young JA, Feagins AR, Basler CF, Fernandez-Sesma A, Becherel OJ, Lavin MF, van Bakel H, Marazzi I.

Nat Immunol. 2015 May;16(5):485-94. doi: 10.1038/ni.3132. Epub 2015 Mar 30.

21.

Stomatin-like protein 2 is required for in vivo mitochondrial respiratory chain supercomplex formation and optimal cell function.

Mitsopoulos P, Chang YH, Wai T, König T, Dunn SD, Langer T, Madrenas J.

Mol Cell Biol. 2015 May;35(10):1838-47. doi: 10.1128/MCB.00047-15. Epub 2015 Mar 16.

22.

Is antigenic sin always "original?" Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish flu.

Gagnon A, Acosta JE, Madrenas J, Miller MS.

PLoS Pathog. 2015 Mar 5;11(3):e1004615. doi: 10.1371/journal.ppat.1004615. eCollection 2015 Mar. No abstract available.

23.

Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus.

Peres AG, Stegen C, Li J, Xu AQ, Levast B, Surette MG, Cousineau B, Desrosiers M, Madrenas J.

Infect Immun. 2015 Apr;83(4):1587-97. doi: 10.1128/IAI.02832-14. Epub 2015 Feb 2.

24.

The role of IL-10 in microbiome-associated immune modulation and disease tolerance.

Levast B, Li Z, Madrenas J.

Cytokine. 2015 Oct;75(2):291-301. doi: 10.1016/j.cyto.2014.11.027. Epub 2014 Dec 23. Review.

PMID:
25542093
25.

Evolving Bacterial Envelopes and Plasticity of TLR2-Dependent Responses: Basic Research and Translational Opportunities.

Li J, Lee DS, Madrenas J.

Front Immunol. 2013 Oct 28;4:347. doi: 10.3389/fimmu.2013.00347. Review.

26.

Identification of multimolecular complexes and supercomplexes in compartment-selective membrane microdomains.

Mitsopoulos P, Madrenas J.

Methods Cell Biol. 2013;117:411-31. doi: 10.1016/B978-0-12-408143-7.00022-0.

PMID:
24143990
27.

Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality.

Gagnon A, Miller MS, Hallman SA, Bourbeau R, Herring DA, Earn DJ, Madrenas J.

PLoS One. 2013 Aug 5;8(8):e69586. doi: 10.1371/journal.pone.0069586. Print 2013.

28.

Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study.

Yasin A, Liu D, Chau L, Madrenas J, Filler G.

BMC Nephrol. 2013 Feb 17;14:39. doi: 10.1186/1471-2369-14-39.

29.

Down-regulation of CTLA-4 by HIV-1 Nef protein.

El-Far M, Isabelle C, Chomont N, Bourbonnière M, Fonseca S, Ancuta P, Peretz Y, Chouikh Y, Halwani R, Schwartz O, Madrenas J, Freeman GJ, Routy JP, Haddad EK, Sékaly RP.

PLoS One. 2013;8(1):e54295. doi: 10.1371/journal.pone.0054295. Epub 2013 Jan 23.

30.

The broad landscape of immune interactions with Staphylococcus aureus: from commensalism to lethal infections.

Peres AG, Madrenas J.

Burns. 2013 May;39(3):380-8. doi: 10.1016/j.burns.2012.12.008. Epub 2013 Jan 11. Review.

PMID:
23313242
31.

Stomatin-like protein 2 deficiency in T cells is associated with altered mitochondrial respiration and defective CD4+ T cell responses.

Christie DA, Mitsopoulos P, Blagih J, Dunn SD, St-Pierre J, Jones RG, Hatch GM, Madrenas J.

J Immunol. 2012 Nov 1;189(9):4349-60. doi: 10.4049/jimmunol.1103829. Epub 2012 Oct 1.

32.

Mitochondrial and plasma membrane pools of stomatin-like protein 2 coalesce at the immunological synapse during T cell activation.

Christie DA, Kirchhof MG, Vardhana S, Dustin ML, Madrenas J.

PLoS One. 2012;7(5):e37144. doi: 10.1371/journal.pone.0037144. Epub 2012 May 18.

33.

High molecular weight polysaccharides are key immunomodulators in North American ginseng extracts: characterization of the ginseng genetic signature in primary human immune cells.

Lemmon HR, Sham J, Chau LA, Madrenas J.

J Ethnopharmacol. 2012 Jun 26;142(1):1-13. doi: 10.1016/j.jep.2012.04.004. Epub 2012 Apr 12.

PMID:
22521964
34.

Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function.

Christie DA, Lemke CD, Elias IM, Chau LA, Kirchhof MG, Li B, Ball EH, Dunn SD, Hatch GM, Madrenas J.

Mol Cell Biol. 2011 Sep;31(18):3845-56. doi: 10.1128/MCB.05393-11. Epub 2011 Jul 11.

35.

A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus.

Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J.

J Infect Dis. 2011 Jul 15;204(2):253-62. doi: 10.1093/infdis/jir276.

PMID:
21673036
36.

Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease.

Filler G, Liu D, Huang SH, Casier S, Chau LA, Madrenas J.

Clin Biochem. 2011 Apr;44(5-6):435-7. doi: 10.1016/j.clinbiochem.2011.01.009. Epub 2011 Feb 1.

PMID:
21291879
37.

The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens.

Nur-ur Rahman AK, Bonsor DA, Herfst CA, Pollard F, Peirce M, Wyatt AW, Kasper KJ, Madrenas J, Sundberg EJ, McCormick JK.

J Biol Chem. 2011 Feb 11;286(6):4871-81. doi: 10.1074/jbc.M110.189068. Epub 2010 Dec 2.

38.

CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice.

Yue D, Brintnell W, Mannik LA, Christie DA, Haeryfar SM, Madrenas J, Chakrabarti S, Bell DA, Cairns E.

Arthritis Rheum. 2010 Oct;62(10):2941-52. doi: 10.1002/art.27597.

39.

TLR2 signalling: At the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus.

Mele T, Madrenas J.

Int J Biochem Cell Biol. 2010 Jul;42(7):1066-71. doi: 10.1016/j.biocel.2010.03.021. Epub 2010 Apr 2. Review.

PMID:
20363358
40.

Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis.

Spence JD, Coates V, Li H, Tamayo A, Muñoz C, Hackam DG, DiCicco M, DesRoches J, Bogiatzi C, Klein J, Madrenas J, Hegele RA.

Arch Neurol. 2010 Feb;67(2):180-6. doi: 10.1001/archneurol.2009.289. Epub 2009 Dec 14. Erratum in: Arch Neurol. 2010 Jun;67(6):706.

PMID:
20008646
41.

Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Hayworth JL, Kasper KJ, Leon-Ponte M, Herfst CA, Yue D, Brintnell WC, Mazzuca DM, Heinrichs DE, Cairns E, Madrenas J, Hoskin DW, McCormick JK, Haeryfar SM.

Clin Exp Immunol. 2009 Jul;157(1):60-70. doi: 10.1111/j.1365-2249.2009.03963.x.

42.

Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.

Xiao W, Hong H, Kawakami Y, Kato Y, Wu D, Yasudo H, Kimura A, Kubagawa H, Bertoli LF, Davis RS, Chau LA, Madrenas J, Hsia CC, Xenocostas A, Kipps TJ, Hennighausen L, Iwama A, Nakauchi H, Kawakami T.

Cancer Cell. 2009 Aug 4;16(2):161-71. doi: 10.1016/j.ccr.2009.05.018.

43.

Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vinés ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J.

Nat Med. 2009 Jun;15(6):641-8. doi: 10.1038/nm.1965.

PMID:
19465927
44.

Structure-Function analysis of the CTLA-4 interaction with PP2A.

Teft WA, Chau TA, Madrenas J.

BMC Immunol. 2009 Apr 30;10:23. doi: 10.1186/1471-2172-10-23.

45.

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P.

J Cell Mol Med. 2008 Dec;12(6B):2552-65. doi: 10.1111/j.1582-4934.2008.00516.x. Review.

46.

Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E.

Stephens TA, Nikoopour E, Rider BJ, Leon-Ponte M, Chau TA, Mikolajczak S, Chaturvedi P, Lee-Chan E, Flavell RA, Haeryfar SM, Madrenas J, Singh B.

J Immunol. 2008 Nov 15;181(10):6859-71.

47.

Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C.

Kasper KJ, Xi W, Rahman AK, Nooh MM, Kotb M, Sundberg EJ, Madrenas J, McCormick JK.

J Immunol. 2008 Sep 1;181(5):3384-92.

48.

Modulation of T cell activation by stomatin-like protein 2.

Kirchhof MG, Chau LA, Lemke CD, Vardhana S, Darlington PJ, Márquez ME, Taylor R, Rizkalla K, Blanca I, Dustin ML, Madrenas J.

J Immunol. 2008 Aug 1;181(3):1927-36.

49.

Characterization of oligomers induced by inverse agonists of CTLA-4.

Teft WA, Madrenas J.

Immunol Lett. 2008 Oct 30;120(1-2):29-36. doi: 10.1016/j.imlet.2008.06.005. Epub 2008 Jul 15.

PMID:
18634825
50.

The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection.

McCully ML, Fairhead T, Blake PG, Madrenas J.

Expert Rev Mol Diagn. 2008 May;8(3):257-61. doi: 10.1586/14737159.8.3.257. Review.

PMID:
18598105

Supplemental Content

Loading ...
Support Center